The Endoscopy Devices Market Report is Segmented by Device Type (Endoscopes [Rigid Endoscopes, and More], Endoscopic Operative Devices [Access Devices, and More], and More), Application (Gastrointestinal, and More), Usability (Reprocessed / Reusable Devices, and More), End-User (Hospitals, Academic Medical Centers, and More) and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global flexible endoscopes market is estimated to be valued at USD 10,186.6 million in 2025 and is projected to reach USD 18,589.8 million by 2035, registering a compound annual growth rate (CAGR) of 6.2% over the forecast period.

Metric	Value
Market Size in 2025	USD 10,186.6 million
Projected Market Size in 2035	USD 18,589.8 million
CAGR (2025 to 2035)	6.2%

Country Wise Outlook

Country	CAGR (2025 to 2035)
USA	57.8%

Country	CAGR (2025 to 2035)
UK	57.5%

Region	CAGR (2025 to 2035)
European Union (EU)	57.6%

Country	CAGR (2025 to 2035)
Japan	57.5%

Country	CAGR (2025 to 2035)
South Korea	57.8%

The Report Covers United States Endoscopy Devices Market Growth Trends and Companies and is segmented by Type of Device (Endoscopes, Endoscopic Operative Devices, and Visualization Equipment), and Application (Gastroenterology, Pulmonology, ENT Surgery, Gynecology, Neurology, Urology, and Other Applications). The Market Size and Forecast are Provided in Terms of Value (In USD Million) for the Above Segments.

The Global Endoscopy Equipment Market size is valued at around USD 29.81 billion in 2023 and is estimated to grow at a CAGR of about 7.12% during the forecast period 2024-30. Leading Companies - Arthrex Inc., B Braun Melsungen, Boston Scientific Corporation, Others

Global Endoscopy Devices Market size is set to expand from $ 30.2 Billion in 2023 to $ 56.51 Billion by 2032, with an anticipated CAGR of around 7.21% from 2024 to 2032.

The Report Covers United Kingdom Endoscopy Devices Market Companies and is segmented by Type of Device (Endoscopes, Endoscopic Operative Devices, and Visualization Equipment) and Application (Gastroenterology, Pulmonology, ENT Surgery, Gynecology, Neurology, Urology, and Other Applications). The Market Size and Forecast are Provided in Terms of Value (In USD Million) for the Above Segments.

Introduction

The Global AI In Endoscopy Market size is expected to be worth around US$ 838.9 Million by 2033 from US$ 58.1 Million in 2023, growing at a CAGR of 30.6% during the forecast period from 2024 to 2033. In 2023, North America held over 48.7% market share, reaching a revenue total of US$ 28.2 Million.

This growth is driven by advancements aimed at enhancing diagnostics and treatment within gastroenterology. A key factor is the improved diagnostic accuracy facilitated by AI, which aids in detecting and characterizing gastrointestinal anomalies, including cancers. Machine learning algorithms analyze endoscopic images to identify subtle lesions often missed through manual observation, thereby improving diagnostic precision and enabling real-time decision-making during procedures.

Operational efficiency further fuels the market’s expansion. AI aids in optimizing endoscopic tool adjustments and procedural navigation, reducing operation times and lowering healthcare costs. Its ability to process large datasets of patient histories and endoscopic images enables predictive analytics, which forecasts patient outcomes and disease recurrence probabilities. This supports personalized treatment strategies and improves patient care management.

AI is also transforming education and training in the field. Advanced AI-powered simulations offer gastroenterologists and endoscopic surgeons immersive, risk-free learning opportunities by simulating various clinical conditions. Additionally, AI fosters collaboration among medical professionals by integrating diverse data types, such as radiological and histological information, into unified platforms, thereby enabling comprehensive patient evaluations and supporting multidisciplinary discussions.

Recent innovations and regulatory approvals reflect the market’s dynamic evolution. For example, in January 2023, AnX Robotica received FDA de novo clearance for its AI-powered tool, NaviCam ProScan, which employs convolutional neural networks to distinguish between normal and abnormal tissue in images. Similarly, in February 2023, AI MedTech firm Waycen announced a strategic sales partnership with MegaMind to distribute its AI solutions across the Middle East. These milestones highlight the growing adoption of AI technologies in endoscopy and underscore the market’s potential, driven by continuous technological progress.

https://sp-ao.shortpixel.ai/client/to_auto,q_lossy,ret_img,w_1218,h_727/https://market.us/wp-content/uploads/2024/03/AI-In-Endoscopy-Market-Size.jpg" alt="AI In Endoscopy Market Size" class="wp-image-116457">

In 2023, laparoscopy applications within the global endoscopy equipment market was worth over ** billion U.S. dollars. By 2029, laparoscopy was forecast to grow to a market size of around **** billion U.S. dollars. Laparoscopy is a procedure to treat and diagnose conditions in the abdomen or pelvic area.

BCC Research for Global Endoscopy Devices is estimated to increase from $51.7 bln in 2022 to reach $75.9 bln by 2027 at a CAGR of 8.0% from 2022 through 2027.

The report covers Germany Endoscopy Companies & Equipment and the market is segmented by Type of Devices (Endoscopes, Endoscopic Operative Devices, Visualization Equipment) and Application (Gastroenterology, Pulmonology, Orthopedics, Cardiology, Gynecology, and Urology, Other Applications). The market provides the value (in USD million) for the above-mentioned segments.

The United States endoscopy devices market, valued at approximately $12.17 billion in 2025, is projected to experience robust growth, driven by a compound annual growth rate (CAGR) of 6.39% from 2025 to 2033. This expansion is fueled by several key factors. The aging population, increasing prevalence of chronic diseases requiring endoscopic procedures (e.g., gastrointestinal disorders, lung cancers), and advancements in minimally invasive surgical techniques are significantly boosting demand. Technological innovations, including the development of sophisticated endoscopes (flexible, rigid, capsule, and robot-assisted), advanced visualization equipment, and improved operative devices, are further enhancing the market's growth trajectory. The rising adoption of minimally invasive procedures, offering advantages like reduced recovery times and shorter hospital stays, is also a major contributor. Furthermore, increased government initiatives promoting advanced medical technologies and favorable reimbursement policies within the US healthcare system contribute to market expansion. Specific segments like flexible endoscopes and robot-assisted systems are expected to show particularly strong growth due to their enhanced capabilities and precision. However, certain challenges remain. High costs associated with advanced endoscopy devices and procedures can hinder market penetration, particularly in underserved populations. Stringent regulatory approvals and reimbursement processes can also impede the introduction of new technologies. Nevertheless, the overall market outlook remains positive, with a significant expansion anticipated throughout the forecast period. Continued innovation, coupled with increasing healthcare expenditure and a rising demand for minimally invasive surgeries, will be pivotal in shaping the future landscape of the US endoscopy devices market. The market segmentation by device type (endoscopes, operative devices, visualization equipment) and application (gastroenterology, pulmonology, etc.) allows for targeted analysis and identification of lucrative sub-segments for manufacturers and investors. Recent developments include: May 2023: Olympus Corporation received the US-FDA clearance of the EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope and the CF-HQ1100DL/I colonovideoscope., January 2023: UC Davis Health launched a new endoscopy suite in the United States characterized by advanced technology and integrated care. This new suite area is more spacious to accommodate the growing volume of endoscopy procedures.. Key drivers for this market are: Rising Preference for Minimally-invasive Surgeries, Increasing Prevalence of Endoscopy for Treatment and Diagnosis; Technological Advancements Leading to Enhanced Applications. Potential restraints include: Rising Preference for Minimally-invasive Surgeries, Increasing Prevalence of Endoscopy for Treatment and Diagnosis; Technological Advancements Leading to Enhanced Applications. Notable trends are: Flexible Endoscope Segment is Estimated to Register Significant Growth Over the Forecast Period.

The global endoscopy devices market size reached USD 50.01 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 85.93 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033. The market is experiencing steady growth driven by the growing adoption of minimally invasive surgeries across various medical fields, the rising prevalence of gastrointestinal diseases and cancer necessitating frequent endoscopic procedures for early detection, and continual technological advancements.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 50.01 Billion
Market Forecast in 2033	USD 85.93 Billion
Market Growth Rate (2025-2033)	5.58%

IMARC Group provides an analysis of the key trends in each segment of the global endoscopy devices market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on type, application and end use.

In 2023, the flexible endoscopy accounted for over *** billion U.S. dollars of the endoscopy equipment market in the Asia-Pacific region. By 2028, flexible endoscopy was forecast to account for over *** billion U.S. dollars of the region's endoscopy equipment market.

According to Cognitive Market Research, the global endoscopy devices market size will be USD 62514.8 million in 2025. It will expand at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2033.

North America held the major market share for more than 40% of the global revenue with a market size of USD 23130.48 million in 2025 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 18129.29 million.
APAC held a market share of around 23% of the global revenue with a market size of USD 15003.55 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2033.
South America has a market share of more than 5% of the global revenue with a market size of USD 2375.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2033.
Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 2500.59 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2033.
Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 1375.33 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2033.
Gastrointestinal surgeries category is the fastest growing segment of the endoscopy devices industry

Market Dynamics of Endoscopy devices Market

Key Drivers for Endoscopy devices Market

Technological Advancements in Endoscopy Devices to Boost Market Growth

The endoscopy devices market is expanding due to continuous technological advancements that enhance diagnostic accuracy, patient comfort, and procedural efficiency. Innovations such as high-definition (HD) imaging, 3D endoscopy, capsule endoscopy, robotic-assisted procedures, and AI-powered diagnostics are driving adoption across hospitals and clinics. Disposable endoscopes are gaining traction due to infection control concerns, while miniaturized and flexible devices allow for deeper and more precise examinations. These advancements improve early disease detection, reduce recovery times, and support minimally invasive surgeries, fueling market growth across gastroenterology, pulmonology, urology, and other medical specialities. The market is expected to grow significantly due to increasing demand for early diagnostics and non-invasive treatments. In September 2024, Inovus Medical unveiled its suite of second-generation modules for the groundbreaking LapAR laparoscopic simulator. These new modules, an evolution of the successful first-generation platform, mark a notable leap in surgical education, boasting improved haptic feedback, heightened anatomical realism, and greater scalability and usability.

https://inovus.org/news/unveils-suite-of-new-modules-for-lapar?srsltid=AfmBOoowAM0nGvB4ZkdQFtEO2IFhMIYam1I9g44sHVt4c4lOIASa71rc

Growing Investments in Healthcare Infrastructure to Boost Market Growth

Growing investments in healthcare infrastructure are a key driver of the endoscopy devices market. Governments and private healthcare providers are expanding hospitals, clinics, and diagnostic centres, improving access to advanced medical technologies. Increased funding supports the adoption of minimally invasive procedures, where endoscopy plays a crucial role in diagnostics and surgeries. Emerging economies are modernizing healthcare facilities, driving demand for cutting-edge endoscopic equipment. Additionally, rising healthcare expenditures, public-private partnerships, and favourable reimbursement policies are encouraging hospitals to invest in high-quality medical devices. This trend enhances patient care, reduces hospital stays, and fosters innovation in endoscopic imaging and robotic-assisted procedures.

Restraint Factor for the Endoscopy Devices Market

High Development Costs Will Limit Market Growth

The high development costs of endoscopy devices act as a significant restraint in the market. Research, prototyping, regulatory approvals, and clinical trials require substantial investment, making innovation expensive. Manufacturers must comply with stringent healthcare regulations, further increasing costs. Advanced technologies like AI-assisted imaging and robotic-assisted endoscopy add to the financial burden. Smaller companies struggle to compete due to high capital requirements, limiting...

Global endoscopes market Share value is expected to touch USD 43.70 billion by 2032, to grow at a CAGR of 8.6% during the forecast period.

The global Endoscopy Devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.63% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of chronic diseases requiring endoscopic procedures, such as gastrointestinal cancers and colorectal disorders, fuels significant demand. Technological advancements in minimally invasive techniques, including robotic-assisted endoscopy and advanced imaging capabilities (e.g., narrow band imaging, chromoendoscopy), are enhancing diagnostic accuracy and therapeutic effectiveness, further propelling market growth. Furthermore, the rising geriatric population, susceptible to age-related digestive issues, contributes significantly to market expansion. A growing preference for outpatient procedures, coupled with the rising adoption of single-use endoscopes to reduce infection risks, adds to the market's momentum. However, market growth is not without challenges. High procedural costs and the need for specialized medical professionals can limit accessibility, particularly in developing regions. Stringent regulatory approvals and reimbursement policies also present hurdles for market players. Despite these restraints, the market is witnessing increased investment in research and development, particularly focusing on artificial intelligence (AI)-powered endoscopy systems that promise improved diagnostic accuracy and streamlined workflows. The competitive landscape features major players like 3M Co., Baxter International Inc., and Medtronic Plc, employing diverse strategies to expand their market share, including strategic collaborations, product innovation, and geographical expansion. This competitive environment fuels further market evolution and innovation.

The global gastrointestinal endoscopy devices market is experiencing robust growth, driven by an aging population with increasing prevalence of gastrointestinal diseases, technological advancements leading to minimally invasive procedures, and rising healthcare expenditure globally. The market's expansion is further fueled by the increasing adoption of advanced endoscopy techniques like capsule endoscopy and single-use endoscopes, offering improved diagnostic accuracy and patient comfort. While the market size and CAGR are not provided, considering the significant advancements and growing demand, a reasonable estimation could place the 2025 market size in the range of $10 billion to $15 billion USD, with a CAGR of 5-7% projected through 2033. This growth trajectory is underpinned by the expansion of endoscopy procedures across various applications, including colorectal cancer screening, diagnosis of peptic ulcers, and the removal of polyps. However, factors like high procedural costs, stringent regulatory approvals, and the potential risks associated with endoscopic procedures act as restraints, potentially slowing the market's overall growth rate. The market is segmented by device type (flexible endoscopes, rigid endoscopes, video processors, and accessories) and application (diagnostic endoscopy, therapeutic endoscopy). Major players like Boston Scientific, Ethicon, Medtronic, Karl Storz, and Olympus are at the forefront of innovation, contributing to the market's competitive landscape through product development and strategic partnerships. Regional growth is expected to be diverse, with North America and Europe currently dominating due to advanced healthcare infrastructure and high adoption rates, while Asia-Pacific is projected to exhibit significant growth driven by rising disposable incomes and increasing healthcare awareness. The competitive landscape is characterized by both large multinational corporations and specialized smaller companies. Strategic acquisitions, partnerships, and technological advancements are key competitive strategies. The future of the market will see continued growth fueled by technological advancements such as artificial intelligence (AI) integration for enhanced image analysis and robotic-assisted endoscopy for improved precision. The increasing demand for minimally invasive procedures, coupled with the development of more sophisticated devices, will drive market expansion, albeit at a pace moderated by the cost constraints and regulatory landscape. Market players are focusing on innovative solutions to address the challenges and capitalize on the opportunities, leading to a dynamic and evolving market structure.

The global gastrointestinal endoscopy market is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24%. In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.

The global Endoscopy Visualization Systems Market is estimated to expand from a value of US$ 1.3 Bn in 2021, to a value of US$ 2.2 Bn by 2028 end, and growing at a CAGR of 7.2% during the forecast period.

Data Points	Market Insights
Market Value 2022	USD 1.4 Billion
Forecasted Global Market Value (2028)	USD 2.2 Billion
Market Growth Rate 2022 to 2028	7.2%
Top 3 Countries % Share	44.9%
Key Players	Olympus Corporation, Pentax Medical Company (Hoya Corporation), Fujifilm Holding Corporation, Karl Storz GmbH & Co KG, Richard Wolf GmbH and Boston Scientific Corporation are the key players in endoscopy visualization systems market. They take about 73% share.

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	7.28%
H1, 2022 Projected	7.19%
H1, 2022 Outlook	7.09%
BPS Change - H1, 2022 (O) - H1, 2022 (P)	(-) 10 ↓
BPS Change – H1, 2022 (O) - H1, 2021	(-) 19 ↓

Scope of the Report

Attribute	Details
Forecast Period	2022 to 2028
Historical Data Available for	2013 to 2021
Market Analysis	USD Million for Value and Volume in Unit
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Spain, Russia, China, Japan, South Korea, India, Australia, New Zealand, GCC Countries, South Africa
Key Segments Covered	Product Type, Area End User and Region
Key Companies Profiled	Olympus Corporation Pentax Medical Company (Hoya Corporation) Fujifilm Holding Corporation Karl Storz GmbH & Co KG Richard Wolf GmbH Boston Scientific Corporation Smith & Nephew ConMed Corporation Stryker Corporation Terumo Corporation DePuy Synthes (Johnson & Johnson Services, Inc.)
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing	Available upon Request

The mobile endoscopic workstations market is expected to reach USD 330.1 Million by 2025 and is expected to steadily grow at a CAGR of 4.4% to reach USD 507.8 Million by 2035. In 2024, mobile endoscopic workstations market have generated roughly USD 316.2 Million in revenues.

Metric	Value
Industry Size (2025E)	USD 330.1 Million
Industry Value (2035F)	USD 507.8 Million
CAGR (2025 to 2035)	4.4%

Country-wise Analysis

Country	CAGR (2025 to 2035)
United States	3.2%

Country	CAGR (2025 to 2035)
Germany	3.8%

Country	CAGR (2025 to 2035)
India	5.6%

Country	CAGR (2025 to 2035)
China	6.2%

Country	CAGR (2025 to 2035)
Japan	4.8%

Competitive Outlook

Company Name	Estimated Market Share (%)
ARC Group of Companies Inc.	33.6%-38.5%
Cura Carts	20.4%-22.6%
EMOS Technology Gmbh	15.1%-17.2%
ENDO-TECHNIK W. Griesat	4.6%-6.8%
Other Companies (combined)	12.1%-15.4%